Cervical cancer screening is a crucial preventive measure aimed at detecting early or precancerous changes in the cervix, often before any symptoms appear. The most common methods include the Pap smear (cytology), HPV testing, or a combination of both, known as co-testing. Early detection through screening allows for timely treatment of abnormal cells, significantly reducing the risk of developing invasive cervical cancer. Most guidelines recommend beginning screening at age 21, with intervals varying based on age, test type, and individual risk factors.
Regular screening is especially important for women with higher risk factors, such as a history of HPV infection, immunosuppression, or smoking, as it improves outcomes and decreases cervical cancer-related mortality. Gain in-depth insights into cervical cancer screening from renowned Gynecologist and Obstetrician Dr. Shehla Jamal in…
